免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Early Detection of Complications During Immunotherapy for Haematological Malignancy

NCT:NCT06377059 · RECRUITING

NCT IDNCT06377059
狀態RECRUITING
開始日期2024-12-02
完成時間2027-07-01
SponsorRigshospitalet, Denmark (OTHER)
First posted
Last updated

簡要摘要

Aims * To identify patients that should remain admitted in hospital for more intense surveillance because of high risk for development of clinical complications * Expand the understanding of the interactions between physiology and immunology for the design of future projects and general knowledge Hypothesis Development of a risk model based on a combination of physiological and immunological parameters can contribute to early detection of patients at risk for clinical complications after anti-cancer treatment.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑